Original Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney)
Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
R. Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, Jozien Helleman, Daan Nieboer, Monique J. Roobol, Lionne D. F. Venderbos, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium
